In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
All content for The Scalpel's Edge is the property of Dr. Tim Sayed and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next Generation of Weight Loss Medications
The Scalpel's Edge
28 minutes
3 months ago
Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next Generation of Weight Loss Medications
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the shifting regulatory landscape for compounded GLP1 medications and what recent FDA warning letters mean for providers, pharmacies, and patients. He also reviews promising new clinical trial data on Pfizer’s experimental drug MET97, which may offer greater weight loss with fewer side effects compared to current options. From the nuances of verbiage in compounding claims to the future of monthly dosing and oral formu...
The Scalpel's Edge
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
